A detailed history of Nordea Investment Management Ab transactions in Biogen Inc. stock. As of the latest transaction made, Nordea Investment Management Ab holds 79,680 shares of BIIB stock, worth $12.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
79,680
Previous 109,474 27.22%
Holding current value
$12.4 Million
Previous $25.4 Million 39.14%
% of portfolio
0.02%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$189.07 - $236.8 $5.63 Million - $7.06 Million
-29,794 Reduced 27.22%
79,680 $15.4 Million
Q2 2024

Aug 08, 2024

BUY
$190.52 - $236.72 $780,750 - $970,078
4,098 Added 3.89%
109,474 $25.4 Million
Q1 2024

May 02, 2024

SELL
$212.02 - $267.71 $6.65 Million - $8.39 Million
-31,354 Reduced 22.93%
105,376 $22.7 Million
Q4 2023

Jan 10, 2024

SELL
$222.59 - $267.94 $18.1 Million - $21.8 Million
-81,258 Reduced 37.28%
136,730 $35.4 Million
Q3 2023

Nov 13, 2023

BUY
$253.3 - $285.89 $19.8 Million - $22.4 Million
78,335 Added 56.09%
217,988 $56 Million
Q2 2023

Jul 07, 2023

SELL
$275.25 - $318.06 $79.9 Million - $92.3 Million
-290,317 Reduced 67.52%
139,653 $39.8 Million
Q1 2023

Apr 19, 2023

BUY
$256.56 - $292.34 $1.54 Million - $1.76 Million
6,005 Added 1.42%
429,970 $120 Million
Q4 2022

Feb 08, 2023

BUY
$252.44 - $306.72 $2.25 Million - $2.74 Million
8,925 Added 2.15%
423,965 $117 Million
Q3 2022

Oct 19, 2022

SELL
$194.69 - $268.46 $1.25 Million - $1.72 Million
-6,408 Reduced 1.52%
415,040 $107 Million
Q2 2022

Aug 09, 2022

SELL
$187.54 - $223.02 $4.97 Million - $5.91 Million
-26,497 Reduced 5.92%
421,448 $85 Million
Q1 2022

Apr 11, 2022

SELL
$193.77 - $244.14 $613,475 - $772,947
-3,166 Reduced 0.7%
447,945 $94.8 Million
Q4 2021

Jan 20, 2022

SELL
$223.92 - $287.77 $1.32 Million - $1.69 Million
-5,875 Reduced 1.29%
451,111 $109 Million
Q3 2021

Nov 01, 2021

SELL
$282.99 - $369.05 $129 Million - $169 Million
-456,986 Reduced 50.0%
456,986 $131 Million
Q3 2021

Nov 01, 2021

BUY
$282.99 - $369.05 $133 Million - $173 Million
468,973 Added 105.39%
913,972 $259 Million
Q2 2021

Jul 16, 2021

SELL
$259.0 - $414.71 $17.7 Million - $28.4 Million
-68,522 Reduced 13.34%
444,999 $154 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $908,875 - $1.06 Million
-3,741 Reduced 0.72%
513,521 $142 Million
Q4 2020

Feb 12, 2021

SELL
$236.26 - $355.63 $734,296 - $1.11 Million
-3,108 Reduced 0.6%
517,262 $127 Million
Q3 2020

Nov 09, 2020

SELL
$264.77 - $305.71 $150 Million - $173 Million
-566,816 Reduced 52.14%
520,370 $147 Million
Q2 2020

Aug 13, 2020

BUY
$258.66 - $342.55 $146 Million - $194 Million
566,347 Added 108.74%
1,087,186 $291 Million
Q1 2020

May 15, 2020

SELL
$268.85 - $341.04 $323,157 - $409,930
-1,202 Reduced 0.23%
520,839 $162 Million
Q4 2019

Feb 11, 2020

BUY
$220.06 - $304.07 $1.91 Million - $2.63 Million
8,660 Added 1.69%
522,041 $155 Million
Q3 2019

Nov 13, 2019

BUY
$217.44 - $243.88 $1.97 Million - $2.21 Million
9,080 Added 1.8%
513,381 $119 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $4.15 Million - $4.58 Million
-18,935 Reduced 3.62%
504,301 $118 Million
Q1 2019

May 20, 2019

BUY
$216.71 - $338.96 $21.2 Million - $33.1 Million
97,622 Added 22.94%
523,236 $124 Million
Q4 2018

Feb 14, 2019

BUY
$278.5 - $352.75 $717,416 - $908,684
2,576 Added 0.61%
425,614 $128 Million
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $736,710 - $963,413
-2,510 Reduced 0.59%
423,038 $149 Million
Q2 2018

Aug 13, 2018

SELL
$257.52 - $306.91 $135,198 - $161,127
-525 Reduced 0.12%
425,548 $124 Million
Q1 2018

May 14, 2018

BUY
$260.13 - $367.91 $17.3 Million - $24.5 Million
66,647 Added 18.54%
426,073 $117 Million
Q4 2017

Feb 12, 2018

BUY
$307.64 - $344.58 $1.76 Million - $1.97 Million
5,710 Added 1.61%
359,426 $115 Million
Q3 2017

Nov 09, 2017

BUY
$281.15 - $329.69 $99.4 Million - $117 Million
353,716
353,716 $111 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Nordea Investment Management Ab Portfolio

Follow Nordea Investment Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Nordea Investment Management Ab with notifications on news.